应对神经退行性疾病：整合帕金森病、阿尔茨海默病和运动神经元疾病中的生物标志物、神经炎症与成像技术
Navigating Neurodegeneration: Integrating Biomarkers, Neuroinflammation, and Imaging in Parkinson's, Alzheimer's, and Motor Neuron Disorders.
作者信息
Tanaka Masaru, Battaglia Simone, Liloia Donato
机构信息
Danube Neuroscience Research Laboratory, HUN-REN-SZTE Neuroscience Research Group, Hungarian Research Network, University of Szeged (HUN-REN-SZTE), Tisza Lajos krt. 113, H-6725 Szeged, Hungary.
Center for Studies and Research in Cognitive Neuroscience, Department of Psychology "Renzo Canestrari", Cesena Campus, Alma Mater Studiorum, University of Bologna, 47521 Bologna, Italy.
出版信息
Biomedicines. 2025 Apr 25;13(5):1045. doi: 10.3390/biomedicines13051045.
Abstract
Neurodegenerative diseases represent a daunting global challenge, affecting millions worldwide and imposing significant clinical and socioeconomic burdens [...].
摘要
神经退行性疾病是一项令人生畏的全球性挑战，影响着全球数百万人，并带来了重大的临床和社会经济负担[……]。
相似文献
1
Navigating Neurodegeneration: Integrating Biomarkers, Neuroinflammation, and Imaging in Parkinson's, Alzheimer's, and Motor Neuron Disorders.
Biomedicines. 2025 Apr 25;13(5):1045. doi: 10.3390/biomedicines13051045.
2
Shared miRNA landscapes of COVID-19 and neurodegeneration confirm neuroinflammation as an important overlapping feature.
Front Mol Neurosci. 2023 Mar 17;16:1123955. doi: 10.3389/fnmol.2023.1123955. eCollection 2023.
3
The Immune System and Neuroinflammation as Potential Sources of Blood-Based Biomarkers for Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.
ACS Chem Neurosci. 2016 May 18;7(5):520-7. doi: 10.1021/acschemneuro.6b00042. Epub 2016 Apr 14.
4
Application of Nanocomposites and Nanoparticles in Treating Neurodegenerative Disorders.
CNS Neurol Disord Drug Targets. 2024;23(10):1217-1233. doi: 10.2174/0118715273283338240104112106.
5
Animal Models of Metabolic Disorders in the Study of Neurodegenerative Diseases: An Overview.
Front Neurosci. 2021 Jan 18;14:604150. doi: 10.3389/fnins.2020.604150. eCollection 2020.
6
Understanding Epigenetic Alterations in Alzheimer's and Parkinson's Disease: Towards Targeted Biomarkers and Therapies.
Curr Pharm Des. 2017;23(5):839-857. doi: 10.2174/1381612823666170124121140.
7
Decoding Neurodegeneration: A Review of Molecular Mechanisms and Therapeutic Advances in Alzheimer's, Parkinson's, and ALS.
Int J Mol Sci. 2024 Nov 24;25(23):12613. doi: 10.3390/ijms252312613.
8
Mitochondrial metabolism: a common link between neuroinflammation and neurodegeneration.
Behav Pharmacol. 2019 Dec;30(8):642-652. doi: 10.1097/FBP.0000000000000505.
9
Unveiling the Potential Neuroprotective Effect of Bioactive Compounds from Plants with Sedative and Mood-Modulating Properties: Innovative Approaches for the Prevention of Alzheimer's and Parkinson's Diseases.
Curr Neuropharmacol. 2025 Feb 11. doi: 10.2174/011570159X345397241210103538.
10
Roles for the adaptive immune system in Parkinson's and Alzheimer's diseases.
Curr Opin Immunol. 2019 Aug;59:115-120. doi: 10.1016/j.coi.2019.07.004. Epub 2019 Aug 17.
引用本文的文献
1
From Microbial Switches to Metabolic Sensors: Rewiring the Gut-Brain Kynurenine Circuit.
Biomedicines. 2025 Aug 19;13(8):2020. doi: 10.3390/biomedicines13082020.
2
Parkinson's Disease: Bridging Gaps, Building Biomarkers, and Reimagining Clinical Translation.
Cells. 2025 Jul 28;14(15):1161. doi: 10.3390/cells14151161.
3
Dualistic Dynamics in Neuropsychiatry: From Monoaminergic Modulators to Multiscale Biomarker Maps.
Biomedicines. 2025 Jun 13;13(6):1456. doi: 10.3390/biomedicines13061456.
本文引用的文献
1
Polyphenols, Alkaloids, and Terpenoids Against Neurodegeneration: Evaluating the Neuroprotective Effects of Phytocompounds Through a Comprehensive Review of the Current Evidence.
Metabolites. 2025 Feb 13;15(2):124. doi: 10.3390/metabo15020124.
2
Oxidative and Excitatory Neurotoxic Stresses in CRISPR/Cas9-Induced Kynurenine Aminotransferase Knockout Mice: A Novel Model for Despair-Based Depression and Post-Traumatic Stress Disorder.
Front Biosci (Landmark Ed). 2025 Jan 20;30(1):25706. doi: 10.31083/FBL25706.
3
Molecular Mechanisms Underlying Neuroinflammation Intervention with Medicinal Plants: A Critical and Narrative Review of the Current Literature.
Pharmaceuticals (Basel). 2025 Jan 20;18(1):133. doi: 10.3390/ph18010133.
4
AdipoRon's Impact on Alzheimer's Disease-A Systematic Review and Meta-Analysis.
Int J Mol Sci. 2025 Jan 8;26(2):484. doi: 10.3390/ijms26020484.
5
Blinded by the Mind: Exploring the Hidden Psychiatric Burden in Glaucoma Patients.
Biomedicines. 2025 Jan 7;13(1):116. doi: 10.3390/biomedicines13010116.
6
Metabolic Dysfunction in Parkinson's Disease: Unraveling the Glucose-Lipid Connection.
Biomedicines. 2024 Dec 13;12(12):2841. doi: 10.3390/biomedicines12122841.
7
Beyond the boundaries: Transitioning from categorical to dimensional paradigms in mental health diagnostics.
Adv Clin Exp Med. 2024 Dec;33(12):1295-1301. doi: 10.17219/acem/197425.
8
Redefining Roles: A Paradigm Shift in Tryptophan-Kynurenine Metabolism for Innovative Clinical Applications.
Int J Mol Sci. 2024 Nov 27;25(23):12767. doi: 10.3390/ijms252312767.
9
Decoding Neurodegeneration: A Review of Molecular Mechanisms and Therapeutic Advances in Alzheimer's, Parkinson's, and ALS.
Int J Mol Sci. 2024 Nov 24;25(23):12613. doi: 10.3390/ijms252312613.
10
Harnessing Brain Plasticity: The Therapeutic Power of Repetitive Transcranial Magnetic Stimulation (rTMS) and Theta Burst Stimulation (TBS) in Neurotransmitter Modulation, Receptor Dynamics, and Neuroimaging for Neurological Innovations.
Biomedicines. 2024 Nov 1;12(11):2506. doi: 10.3390/biomedicines12112506.
Zotero 插件